SCHEMBL5045709

SCHEMBL5045709

CCOC(=O)C(OCC)c1c(F)cc(O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)cc1F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 1/20 0.34
KDM4E B2RXH2 2/20 0.34
F10 P00742 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
FFAR1 O14842 1/20 0.32
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
ALDH1A1 P00352 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MMP8 P22894 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043183 0.87 PIN1 (0.36) PIN1MEN1KMT2ANPC1KDM4E
SCHEMBL5041209 0.83 PIN1 (0.34) PIN1MEN1KMT2ANPC1KDM4E
SCHEMBL5043096 0.74 PIN1 (0.34) PIN1MEN1KMT2ANPC1GAA
SCHEMBL5042607 0.74 CYP3A4 (0.40) MEN1KMT2ANPC1TDP1GAA
SCHEMBL5038093 0.73 CXCR2 (0.36) KMT2AFFAR1SMN1; SMN2POLBHTT
SCHEMBL5045526 0.72 F10 (0.54) MEN1KMT2ANPC1KDM4EF10
SCHEMBL5043173 0.72 CYP2C9 (0.39) PIN1MEN1KMT2ANPC1LMNA
SCHEMBL5041213 0.72 PIN1 (0.35) PIN1MEN1KMT2ANPC1KDM4E
SCHEMBL5042392 0.71 CA12 (0.42) TDP1GAAHPGDSMN1; SMN2
SCHEMBL5042882 0.71 PTGS2 (0.41) MEN1KMT2ANPC1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PIN1 3824/4885MEN1 766/4885KMT2A 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.